DNLI Market Cap & Key Metrics
Denali Therapeutics Inc.
$17.87
-$0.53(-2.88%)
39
Overall
60
Value
18
Tech
39
Quality
Market Cap
$2.86B
Volume
2.70M
52W Range
$13.75 - $27.30
Target Price
$35.41
DNLI market cap is $2.86B. This page lists Denali Therapeutics Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
DNLI Key Metrics
- Market cap
- $2.86B
- EPS estimate, current year
- $-2.67
- EPS growth, 3-year
- -4.53%
- Value score
- 60
- Quality score
- 39
- Technical score
- 18
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | - | $330.53M | $105.06M | $48.66M |
| EBITDA | -$507.88M | -$463.37M | -$172.45M | -$315.57M | -$287.16M |
| EPS | $-2.97 | $-2.57 | $-1.06 | $-2.60 | $-2.39 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNLI | $17.87 | -2.9% | 2.70M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Denali Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW